Wellington Management Group
MYGN icon

Wellington Management Group’s Myriad Genetics MYGN Stock Holding History

Wellington Management Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,592,264
Closed -$40.7M – 2014
2025
Q1 		$40.7M Sell
4,592,264
-1,412,334
-24% -$17M 0.01% 743
2024
Q4 		$82.3M Sell
6,004,598
-711,985
-11% -$13.1M 0.02% 577
2024
Q3 		$184M Sell
6,716,583
-1,545,842
-19% -$41.8M 0.03% 412
2024
Q2 		$202M Buy
8,262,425
+202,424
+3% +$4.44M 0.04% 378
2024
Q1 		$172M Buy
8,060,001
+840,295
+12% +$18.1M 0.03% 418
2023
Q4 		$138M Buy
7,219,706
+1,223,446
+20% +$21.2M 0.03% 485
2023
Q3 		$96.2M Buy
5,996,260
+251,426
+4% +$4.78M 0.02% 539
2023
Q2 		$133M Sell
5,744,834
-986,005
-15% -$21.5M 0.03% 480
2023
Q1 		$156M Sell
6,730,839
-56,384
-0.8% -$1.15M 0.03% 441
2022
Q4 		$98.5M Buy
6,787,223
+824,001
+14% +$15.4M 0.02% 526
2022
Q3 		$114M Buy
5,963,222
+480,696
+9% +$11M 0.02% 483
2022
Q2 		$99.6M Buy
5,482,526
+386,291
+8% +$8.02M 0.02% 539
2022
Q1 		$128M Buy
5,096,235
+770,460
+18% +$19.7M 0.02% 530
2021
Q4 		$119M Buy
4,325,775
+1,094,563
+34% +$31.7M 0.02% 586
2021
Q3 		$104M Buy
3,231,212
+2,238,076
+225% +$74.3M 0.02% 610
2021
Q2 		$30.4M Buy
993,136
+114,202
+13% +$3.3M 0.01% 991
2021
Q1 		$26.8M Buy
+878,934
New +$24.9M ﹤0.01% 996
2020
Q1 		– Sell
-16,648
Closed -$454K – 2001
2019
Q4 		$454K Sell
16,648
-10,424
-39% -$287K ﹤0.01% 1870
2019
Q3 		$775K Sell
27,072
-77,714
-74% -$2.26M ﹤0.01% 1776
2019
Q2 		$2.91M Buy
104,786
+12,302
+13% +$347K ﹤0.01% 1524
2019
Q1 		$3.07M Buy
92,484
+29,336
+46% +$893K ﹤0.01% 1505
2018
Q4 		$1.83M Buy
63,148
+41,483
+191% +$1.49M ﹤0.01% 1661
2018
Q3 		$997K Buy
21,665
+1,413
+7% +$62.8K ﹤0.01% 1875
2018
Q2 		$757K Buy
20,252
+9,505
+88% +$321K ﹤0.01% 1953
2018
Q1 		$318K Buy
+10,747
New +$364K ﹤0.01% 2084
2017
Q1 		– Sell
-35,793
Closed -$597K – 2287
2016
Q4 		$597K Sell
35,793
-65,100
-65% -$1.18M ﹤0.01% 1971
2016
Q3 		$2.08M Sell
100,893
-78,780
-44% -$2M ﹤0.01% 1638
2016
Q2 		$5.5M Buy
179,673
+3,600
+2% +$125K ﹤0.01% 1312
2016
Q1 		$6.59M Buy
176,073
+46,316
+36% +$1.75M ﹤0.01% 1274
2015
Q4 		$5.6M Buy
129,757
+118,557
+1,059% +$5.01M ﹤0.01% 1326
2015
Q3 		$420K Buy
+11,200
New +$398K ﹤0.01% 1992
2014
Q4 		– Sell
-21,045
Closed -$812K – 2210
2014
Q3 		$812K Buy
21,045
+174
+0.8% +$6.49K ﹤0.01% 1873
2014
Q2 		$812K Sell
20,871
-127,260
-86% -$4.73M ﹤0.01% 1867
2014
Q1 		$5.07M Sell
148,131
-115,706
-44% -$3.58M ﹤0.01% 1452
2013
Q4 		$5.54M Sell
263,837
-2,600
-1% -$65.8K ﹤0.01% 1428
2013
Q3 		$6.26M Sell
266,437
-8,213
-3% -$233K ﹤0.01% 1376
2013
Q2 		$7.38M Buy
+274,650
New +$7.96M ﹤0.01% 1293

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Wellington Management Group's MYGN Position: Q2 2025 in Review

Wellington Management Group sold out of Myriad Genetics (MYGN) in Q2 2025, closing a stake of 4,592,264 shares — an estimated $40.7M sold.

Wellington Management Group first reported a position in MYGN in Q2 2013 and held it in 37 quarters. The position peaked at $202M in Q2 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q2 2025.

  • Wellington Management Group reported no remaining Myriad Genetics position as of Q2 2025 after selling out during the quarter.
  • Wellington Management Group sold 4,592,264 Myriad Genetics shares in Q2 2025, an estimated $40.7M.
  • Wellington Management Group first reported a position in Myriad Genetics in Q2 2013 and held it in 37 quarters.
  • Wellington Management Group's Myriad Genetics position peaked at $202M in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2025.

Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.